Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Science Policy Fellowships

Direct Payment

$17,500.00

Development of Risk Assessment and Regulatory Strategy for addressing Nanomedicine under the Food and Drugs Act

EF 2011-12

Résumé
Nanotechnological innovations are changing the way we interact with the world and their application in the medical field holds the potential to greatly benefit the health of the Canadian population. However, the implication of new technologies cannot be assumed to be risk free as any beneficial properties may be accompanied by unforeseen problems. As such, the overall goal of this work is to facilitate the regulation and safe integration, of emerging nanomedical technologies, into existing medical policy and practice. To achieve these goals this work will encompass a review of studies relating to the safety and risk assessment of current nanomedicine. The state of current domestic and international policies governing the regulation of nanomedicine will also be reviewed. Additionally, this work will involve the consultation of scientists involved in the development new nanomedical applications, consultation of experts in the field of risk assessment related to nanotechnologies and the communication with businesses involved in the development of future nanomedical applications. This compilation of data should highlight the current state of nanomedical regulation and also bring to light potential gaps in regulation and risk assessment of current and emerging nanomedical applications. As such, the report generated from this study will be invaluable in the development of future procedures for the generation of nanomedical regulatory and risk assessment policies.
Programme
Science Policy Fellowships
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
234952
Name
Walsh Ryan
Region
Ontario
Country
Canada
Orgtype
Research Institution
Partnername
HC - Strategic Policy Branch
Instname2
Health Services and Policy Research
Theme2
Biomedical
Prcname2
Science Policy Fellowships
Projecttitle
Development of Risk Assessment and Regulatory Strategy for addressing Nanomedicine under the Food and Drugs Act
Programtype2
Undefined
Orgnameinp2
Direct Payment
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Science Policy Fellowships
Keyworddelim
Nanomedicine; Regulatory Strategy; Risk Assessment
Abstract
Nanotechnological innovations are changing the way we interact with the world and their application in the medical field holds the potential to greatly benefit the health of the Canadian population. However, the implication of new technologies cannot be assumed to be risk free as any beneficial properties may be accompanied by unforeseen problems. As such, the overall goal of this work is to facilitate the regulation and safe integration, of emerging nanomedical technologies, into existing medical policy and practice. To achieve these goals this work will encompass a review of studies relating to the safety and risk assessment of current nanomedicine. The state of current domestic and international policies governing the regulation of nanomedicine will also be reviewed. Additionally, this work will involve the consultation of scientists involved in the development new nanomedical applications, consultation of experts in the field of risk assessment related to nanotechnologies and the communication with businesses involved in the development of future nanomedical applications. This compilation of data should highlight the current state of nanomedical regulation and also bring to light potential gaps in regulation and risk assessment of current and emerging nanomedical applications. As such, the report generated from this study will be invaluable in the development of future procedures for the generation of nanomedical regulatory and risk assessment policies.
Competitiondate
201106
Approvedterm2
0 yr 6 mths
Pinamesdelim
Walsh, Ryan
Approvedterm
0 an 6 mois
Cihrcontribution2
Knowledge Translation Branch~ $17,500~ $0~